ArticleScientific reports2025

Real-world efficacy and safety of pembrolizumab plus lenvatinib in patients with metastatic renal cell carcinoma: a multi-institutional retrospective study.

Taigo Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.